These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18811133)

  • 1. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
    Altenbach RJ; Adair RM; Bettencourt BM; Black LA; Fix-Stenzel SR; Gopalakrishnan SM; Hsieh GC; Liu H; Marsh KC; McPherson MJ; Milicic I; Miller TR; Vortherms TA; Warrior U; Wetter JM; Wishart N; Witte DG; Honore P; Esbenshade TA; Hancock AA; Brioni JD; Cowart MD
    J Med Chem; 2008 Oct; 51(20):6571-80. PubMed ID: 18811133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.
    Cowart MD; Altenbach RJ; Liu H; Hsieh GC; Drizin I; Milicic I; Miller TR; Witte DG; Wishart N; Fix-Stenzel SR; McPherson MJ; Adair RM; Wetter JM; Bettencourt BM; Marsh KC; Sullivan JP; Honore P; Esbenshade TA; Brioni JD
    J Med Chem; 2008 Oct; 51(20):6547-57. PubMed ID: 18817367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
    Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
    J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
    Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
    Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands.
    Schreeb A; Walter M; Odadzic D; Schwed JS; Weizel L; Stark H
    Pharmazie; 2013 Jul; 68(7):521-5. PubMed ID: 23923631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.
    Engelhardt H; Schultes S; de Graaf C; Nijmeijer S; Vischer HF; Zuiderveld OP; Dobler J; Stachurski K; Mayer M; Arnhof H; Scharn D; Haaksma EE; de Esch IJ; Leurs R
    J Med Chem; 2013 Jun; 56(11):4264-76. PubMed ID: 23668417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
    Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H4 receptor ligands and their potential therapeutic applications.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
    Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
    Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
    Savall BM; Chavez F; Tays K; Dunford PJ; Cowden JM; Hack MD; Wolin RL; Thurmond RL; Edwards JP
    J Med Chem; 2014 Mar; 57(6):2429-39. PubMed ID: 24495018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure-activity relationship (SAR).
    Masood MA; Selby MD; Bell AS; Mansfield AC; Gardner M; Smith GF; Lane C; Kenyon-Edwards H; Osborne R; Jones RM; Liu WL; Brown CD; Clarke N; Perrucio F; Mowbray CE
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6591-5. PubMed ID: 21955944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first potent and selective non-imidazole human histamine H4 receptor antagonists.
    Jablonowski JA; Grice CA; Chai W; Dvorak CA; Venable JD; Kwok AK; Ly KS; Wei J; Baker SM; Desai PJ; Jiang W; Wilson SJ; Thurmond RL; Karlsson L; Edwards JP; Lovenberg TW; Carruthers NI
    J Med Chem; 2003 Sep; 46(19):3957-60. PubMed ID: 12954048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
    Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
    Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
    Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.
    Venable JD; Cai H; Chai W; Dvorak CA; Grice CA; Jablonowski JA; Shah CR; Kwok AK; Ly KS; Pio B; Wei J; Desai PJ; Jiang W; Nguyen S; Ling P; Wilson SJ; Dunford PJ; Thurmond RL; Lovenberg TW; Karlsson L; Carruthers NI; Edwards JP
    J Med Chem; 2005 Dec; 48(26):8289-98. PubMed ID: 16366610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pK(a) on pyrimidine/pyridine-derived histamine H4 ligands.
    Savall BM; Meduna SP; Venable J; Wei J; Smith RC; Hack MD; Thurmond RL; McGovern P; Edwards JP
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5489-92. PubMed ID: 25455490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.